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Abstract 
Albeshri, Hind Obaid. M.S. Microbiology and Immunology Graduate Program, Wright 
State University, 2014. Effect of Herpes Simplex Virus-1 on Macrophage CD Marker 
Expression. 
 
Macrophages are specialized phagocytic cells derived from the peripheral blood 
mononuclear cells. Macrophages can assume M1 or M2 cellular states upon activation 
with specific cytokines. Upon activation, macrophages produce either pro- or anti-
inflammatory cytokines and thereby perform their functions of antigen engulfment and 
debris clearance. Macrophages have several cell surface cluster differentiation (CD) 
markers including CD80, CD163 and CD200R that differentiate M1 macrophages from 
M2. Downstream signaling and cytokine production varies based on the interaction 
between the specific CD marker and antigen. 
The present study was aimed at analyzing and comparing the effects of HSV-1 
infection on un-polarized and polarized macrophages at 18, 24, and 48 hours. RAW 
264.7 murine macrophage cell lines were cultured under standard conditions and 
activated appropriately for obtaining M1 and M2 cells. The expression of CD markers 
and cell viability prior to and post infection was determined by immunofluorescence 
staining and flow cytometry, respectively. Data were analyzed using Student’s t test and 
one-way ANOVA.  
Polarization led to morphological changes in RAW264.7 macrophages. M1 cells 
were large, elongated, vacuolated and strongly adherent, and showed a significant 
decrease in cell viability over time after cytokine treatment. M2 macrophages retained 
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more of their original M0 phenotype, appearing rounded, and they exhibited a slight 
decrease in cell viability. Before viral infection, CD80 expression was highest in M1 cells 
and CD200R expression was highest in M2 cells. CD163 expression was high in both M1 
and M2 (IL-4 activated), but not in M2 (IL-10 and IL-13 activated) cells. Following 
HSV-1 challenge (MOI 0.1), morphologies of both uninfected and infected M1 and M2 
cells were similar. Virus infected M1 macrophages showed further decreases in cell 
viability compared to uninfected M1 macrophages. The levels of CD markers altered 
depending on their pro- or anti-inflammatory nature. CD80 expression decreased, 
although not significantly, in M1 cells infected with HSV-1 compared to uninfected M1 
phenotype, suggesting that this is a specific M1 macrophage cell-surface marker that 
promotes pro-inflammatory immune responses. CD163 expression was higher in IL-10 
activated M2 macrophages after viral infection; however, this was also not statistically 
significant. The only statistical significance was found with CD200R expression. 
CD200R was found at significantly higher levels in M2 macrophages compared with the 
M1 phenotype. This suggested that higher expression of CD200R might serve to block 
the pro-inflammatory pathway.  
.  
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Hypothesis 
 
This study addresses the hypothesis that M0 Raw 264.7 macrophages polarized into M1 
or M2 phenotypes show distinctive cell morphology, viability, expression levels of CD 
markers: CD80, 163, and 200R at 18, 24, and 48 hours before and after Herpes Simplex 
Virus-1 infection. These characteristics help to distinguish between the M1 and M2 
phenotypes. 
 
The specific goals of this study are: 
 
• To examine the morphology and viability of polarized macrophages, M1 activated 
by LPS/IFN-γ and M2 activated by each of IL-4, IL10, or IL-13, post HSV-1 
infection at 18, 24, and 24 hours. 
• To examine the effect of HSV-1 infection on expression levels of CD80, CD163, 
and CD200R in M0, M1 and M2 macrophages at 18, 24, and 48 hours and 
compare them to uninfected polarized macrophages subpopulations. 
• To study the expression of CD markers before and after virus infection at 24 
hours using flow cytometry analysis.  
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Introduction 
 
Macrophages are specialized cells originating from the peripheral blood mononuclear 
cells of the bone marrow. Macrophages are phagocytic in nature and engulf antigens, 
leading to an immune cascade that ends in the production of specific pro- and anti-
inflammatory cytokines that cause alterations in cellular homeostasis. They also help 
clear viruses and tissue debris from day to day body functions (Mosser & Edwards, 
2008). 
 Macrophages are activated through specific cytokine signals. They acquire 
multiple phenotypes: classically activated macrophages (M1) and alternative activated 
macrophages (M2). Classically activated macrophages were known first, require a 
priming signal, such as interferon gamma (IFN-y), and encounter an appropriate stimulus 
like bacterial lipopolysaccharides (LPS) (Huang et al. 1993). In the presence of LPS, the 
cells assume an M1 phenotype via the classical pathway of activation (Mosser & 
Edwards, 2008). Classical activated macrophages exhibit a Th1-like phenotype, 
promoting inflammation, extracellular matrix (ECM) destruction, and apoptosis 
(Mantovani, 2006) and produce pro-inflammatory cytokines including IL-12 and IL-23 
(Mantovani, 2006). Conversely, alternative activated macrophages were described later 
do not require any priming signal (Stein et al. 1992). They have distinct morphology and 
characteristics from classically activated macrophages. Anti-inflammatory cytokines, 
such as IL-4, IL-10 and IL-13, trigger macrophages to proceed via the alternate pathway 
of activation and assume an M2 phenotype. These cells in turn produce low levels of IL-
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12 and high levels of IL-10 (Mantovani, 2006). They exhibit a Th2-like phenotype, 
promoting ECM construction, angiogenesis, and cell proliferation (Mantovani, 2006). 
 The Herpes Simplex Virus (HSV) is a double stranded DNA virus with a 
protective capsid of proteins (Egan et al., 2013). HSV-1 enters the body through the oral 
epithelium and, through primary altered nerve endings, reaches dorsal root ganglia 
infecting them and producing herpetic neuralgia. The infection process is complicated 
with the temporal and highly regulated expression of viral genes, and specific alterations 
in the viral life cycle including virulence, latency and reactivation (Egan et al., 2013). 
The host response to HSV-1 is primarily mediated by macrophages and natural killer 
cells (Erikksen, 2005). These viral antigens are bound by the cell surface markers on 
these cells, which initiate signaling cascades. For example, binding of HSV-1 to 
macrophage toll-like receptor (TLR) – 9 initiates the MyD88 signaling pathway that 
results in the production of IFN-γ (Wang et al., 2011). Several mechanisms of action of 
macrophages in the elimination of HSV-1 have been proposed, these include the 
production of reactive oxygen species  (ROS), nitric oxide (NO), and Suppressors of 
Cytokine Signaling (SOCS) proteins via the JAK-STAT pathway (Mott et al., 2009; 
Arnold et al., 2014). 
 The response of macrophages to HSV-1 infection varies significantly depending 
on the type of cell surface marker bound by the antigen. Macrophages have several 
clusters of differentiation (CD) markers including CD80, CD163 and CD200R on their 
surface. The specific interactions between these markers and their ligands on the viral 
surface result in the production of specific cytokines. Studying these interactions would 
therefore help in understanding the fundamental mechanisms of macrophage activation 
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and action. The aim of the present study is to assess the changes in morphology, 
cytotoxicity and expression of CD80, CD163 and CD200R expression before and after 
HSV-1 infection in M1 and M2 polarized macrophages. Macrophages are activated by 
LPS and IFN-γ (for M1 state) and by IL-4, IL-10 and IL-13 (for an M2 state). The effect 
of HSV-1 infection is assessed through the expression levels of CD80, CD163 and 
CD200R markers in M0, M1 and M2 cells at 18, 24 and 48 hours post infection and these 
results are compared with those of uninfected cells. The hypothesis of this study is that 
M0 RAW 264.7 macrophages polarized into M1 or M2 phenotypes will show distinctive 
cell morphology, viability, expression levels of CD80, 163, and 200R at 18, 24, and 48 
hours before and after Herpes Simplex Virus-1 infection. These characteristics will 
provide further details to allow researchers to distinguish between the M1 and M2 
phenotypes following polarization. 
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Literature Review 
 
Macrophages – Origin, Tissue distributions, and Functions 
Macrophages are derived from peripheral blood mononuclear (PBM) cells, which are 
formed in the bone marrow. PBM cells differentiate into monocytes that circulate in the 
blood for about 36 hours, after which they settle in different tissues as macrophages and 
take on functions specific to these tissues (Ellermann-Eriksen, 2005). Macrophages are 
ubiquitous and are found in several tissues including skin (Langerhans cells), bone 
(osteoclasts), liver (Kupffer cells), lungs (alveolar and interstitial macrophages), and the 
central nervous system (microglia) (Ellermann-Eriksen, 2005). 
In the presence of pathogenic antigens, macrophages bind to and engulf these 
antigens initiating an immune response that includes the activation of genes for the 
production of cytokines like Interferon γ (IFN-γ) and tumor necrosis factor α (TNFα). 
Apart from their immunological role as phagocytic cells against microbes, macrophages 
also perform homeostatic functions and assist by clearing about 2 x 1011 erythrocytes 
from tissues each day, allowing for the recycling of iron and heme (Menzies et al, 2010; 
Mosser & Edwards, 2008). 
Macrophages also help in wound healing and in clearing cell debris that result 
from damaged and apoptosed cells (Mosser & Edwards, 2008). Receptors present on un-
stimulated macrophages include scavenger receptors, complement receptors and 
phosphatidyl serine receptors that help mediate the homeostatic functions of macrophages 
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independent of immune response (Mosser & Edwards, 2008). Thus, macrophages exist in 
two states – activated and inactivated, performing specific functions in each state. 
Macrophage Activation and Subtypes 
The process by which macrophages are induced to assume antimicrobial activities is 
called “macrophage activation” (Sica & Mantovani, 2012; Mantovani, 2006). 
Macrophages acquire different phenotypes based on their tissue environment. Each 
phenotype differs in the type of cell surface markers that are induced while others are 
suppressed. Therefore, it has been suggested that macrophage classification may be more 
accurately made based on function (Sica & Mantovani, 2012; Mantovani, 2006).  
Macrophage activation occurs with the help of multiple cytokine signals. In the 
presence of IFN-γ, TNFα, Granulocyte-Macrophage Colony Stimulating Factor (GM-
CSF), or microbial lipopolysaccharides (LPS), Toll Like Receptor  (TLR) is activated, 
causing macrophages to assume an “M1” phenotype (Mosser & Edwards, 2008; 
Mantovani, 2006). This process of macrophage activation is called the classical pathway. 
M1 macrophages produce high levels of reactive oxygen species (ROS), reactive nitrogen 
species (RNS), Interleukin (IL)-12 and IL-23 and low levels of IL-10, taking on a pro-
inflammatory role (Mantovani, 2006). ). Classical activated macrophages exhibit a Th1-
like phenotype and promote inflammation, ECM destruction, and apoptosis (Mantovani, 
2006). In addition, matrix metalloproteases (MMP), such as MMP-1, 3, 7, 10 and 12, are 
stimulated during activation of the classical pathway (Huang et al, 2012). 
In the presence of cytokines including IL-4, IL-10, or IL-13, as well as 
glucocorticoid hormones, alternate pathways of macrophage activation are triggered and 
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lead to the generation of the macrophage polarization phenotype collectively called “M2” 
(Mantovani, 2006). In contrast to M1 cells, M2 macrophages produce low levels of IL-12 
and IL-23 and high levels of IL-10. In addition, M2 cells are involved in  theTH2 (not TH1 
like M1 cells) cell mediated immune response (Pesce et al, 2006; Mantovani, 2006). 
Differentiation of one macrophage to either an M1 or M2 state causes neighboring 
macrophages to also take the same phenotype (M1 or M2) and inhibit the other state 
(Chawla, 2010; Odegaard & Chawla, 2011). 
One of the most reliable means of functionally differentiating M1 and M2 cells is 
by determining the way in which the cells metabolize the amino acid arginine (Odegaard 
& Chawla, 2011). M1 cells produce nitric oxide synthase, an enzyme that catabolizes 
arginine into nitric oxide and citrulline (Odegaard & Chawla, 2011). The nitric oxide acts 
as a bactericidal agent, helping these pro-inflammatory cells to fight bacterial infections. 
M2 cells, on the other hand, produce arginase 1 that uses arginine to produce urea and 
other polyamines that are required for collagen synthesis (Odegaard & Chawla, 2012; 
Murray & Wynn, 2012). 
As previously mentioned, the activation of M1 cells occurs through the previously 
described classical pathway. In the presence of bacterial LPS or IFN-γ, Toll-like receptor 
4 (TLR4) is activated, resulting in the initiation of downstream signaling via the MyD88 
protein. The classical pathway results in the stimulation of TNF that acts along with IFN-
γ in an autocrine manner to activate the M1 phenotype (Mosser & Edwards, 2008). Based 
on their cell surface markers and functions, M2 macrophages are further divided into 4 
subtypes – M2a, M2b, M2c and M2d (Martinez & Gordon, 2014; Porcheray et al, 2005). 
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To provide a global picture of the genetic changes occurring in macrophages 
during and following activation, Zhang et al (2010) performed transcriptional profiling of 
macrophages activated in the presence of LPS, protozoan pathogens Trypanosoma cruzi 
and Leishmania mexicana and cytokines like IFN-γ, TNFα and IL-10. The presence of 
LPS activated macrophages via the classical pathway and changes in transcription could 
be seen in ~236 genes (Zhang et al, 2010). In the presence of L. mexicana, only ~3 genes 
showed any transcriptional changes while about 72 genes showed altered transcription in 
the presence of T. cruzi. While LPS-mediated macrophage activation was similar to that 
seen with IFN-γ and TNFα, activation with parasitic pathogens mimicked the alternate 
activation pathway similar to that mediated by IL-10 (Zhang et al, 2010). 
Herpes Simplex Virus  
Herpes Simplex Virus (HSV) is a ubiquitous viral species that belongs to the 
Alphaherpesvirinae. The two main types are HSV-1 and HSV-2; the two types are 
closely related and share 83% genomic identity (Erikksen, 2005). HSV-1’s immense 
genetic diversity is demonstrated by genome-wide sequencing analysis of ~20 viral 
genomes from different countries around the world (Szpara et al, 2013). HSV has a long 
phylogeny and studies have shown that HSV has co-evolved with humans, making the 
viruses readily adaptable to most human immune responses (Erikksen, 2005). HSV 
infections can, in the long run, bring about production of β-amyloid proteins and cause 
phosphorylation of the tau protein, both involved in the pathogenesis of Alzheimer’s 
disease (Conrady et al, 2010). HSV infection can also bring about extensive destruction 
of the central nervous system and the ability of the virus to evade host immune response 
makes this a complicated virus. 
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HSV-1 is a double stranded icosahedral DNA virus with a genome size of 152kb, 
19 open reading frames (ORFs) and upwards of 84 genes. The genome is enclosed within 
the nucleocapsid that is surrounded by a group of proteins called the tegument (Egan et 
al, 2013). The outer lipid envelope contains at least 10 different glycoproteins (gB-E, gG-
M) which have a multitude of functions during viral entry into the host cell and infection 
and transcription of early viral genes (Erikksen, 2005). 
The infection cycle of HSV-1 has been extensively researched and includes a 
complex cascade of events that are dependent on the outer envelope glycoproteins. HSV-
1 gB and gC proteins interact with heparin sulphate proteoglycans or paired 
immunoglobulin like type 2 receptor alpha (PILRα) on the host cell membrane, thereby 
allowing the virus to contact the host cell (Egan et al, 2013; Arii et al, 2009). In the next 
step of infection, viral gD interacts with host cell membrane receptors like Herpes Virus 
Entry Protein A (HveA), nectin-1 and nectin-2 and the subsequent conformational change 
in gD allows for its association with gB, gH and gL (Egan et al, 2013; Erikksen, 2005). 
This allows the virus to fuse with the host cell by an unidentified mechanism (Figure 1) 
(Erikksen, 2005; Bigley, 2014). Following fusion, the tegument proteins allow for the 
entry of the nucleocapsid into the host cell. This helps the virus to escape the host 
immune response and, through interaction with host proteins (e.g., HCF1 and OCT1), 
initiate expression of early viral genes (Egan et al, 2013). 
HSV-1 genes are expressed in a sequential fashion, with each set of activated 
genes stimulating the transcription of the genes next in line (Egan et al, 2013). The viral 
proteins produced then aid in creating more progeny virions, which are encapsulated and 
released from the host cell through vesicles or through host cell lysis (Egan et al, 2013). 
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Viral replication is usually inhibited in macrophages through several mechanisms, one of 
which involves the protein SAMHD1 that is present in monocytes as well. SAMHD1 
blocks the activity of the viral reverse transcriptase in multiple non-dividing macrophage 
cell lines (Kim et al, 2013). 
 
Figure 1. The infection cycle of HSV-1 includes viral glycoproteins interaction with cell 
surface receptors, viral entry, and viral replication [No changes have been made. 
Adapted from Bigley, 2014] 
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HSV-1 is capable of progressively binding to cells adjacent to infected and lysed 
cells in order to continue its infection cycle. This efficient mechanism requires the gE and 
gI proteins of the virus and enables the virus to escape the antibodies or complement 
proteins which are found in the extra cellular space (Erikksen, 2005). Viral infection 
leads to localized necrosis of host cell. While this is not especially serious in cells with 
high regenerative capabilities, it can be life-threatening or debilitating if the virus infects 
nerve cells. The toxins released by the virus, along with the large immune response 
generated, can cause increased intra-cranial pressure and systemic complications 
(Erikksen, 2005). 
HSV-1 Pathogenesis and Latency 
HSV-1 infection is manifested as blisters or sores in the mucoepithelial layer of the oral 
cavity, skin and genital regions. The oral cavity is the preferred site as it provides the 
optimal conditions for survival and transmission of the viral particles (Grinde, 2013). The 
general mechanism of viral pathogenesis involves the entry and establishment of the virus 
in the host body such that it can co-exist with the host. In fact, when transmission occurs 
early in life, viral establishment leads to host viremia with little malaise (Grinde, 2013). 
Late viral entry and infection usually leads to disease state because the immune system of 
the host is completely developed (Grinde, 2013).  
HSV-1 mediated infection occurs more readily in the immunocompromised host, 
like one with a pre-existing HIV infection. Sufiawali & Tugizov (2014) analyzed the 
effects of HIV-mediated disruption of oral epithelial tight junctions on the spread of HSV 
infections. These investigators exposed oral epithelial cells to HIV gp120 and tat proteins 
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and found that the integrity of the tight and adherens junctions was compromised. In 
addition, these alternations in functional complexes led to the exposure of the nectin-1 
surface receptor on the epithelia. Nectin-1 is the primary receptor that binds to HSV-1 gD 
protein to initiate viral entry (Sufiawali & Tugizov, 2014). Easier access to this receptor 
in the presence of HIV infection causes greater transmission of HSV-1 from the initial 
site of infection to neighboring cells of the epithelium (Sufiawali & Togizov, 2014). 
HSV infections usually proceed through an initial period of rapid viral replication, 
increased viral loads in the host and high risk of transmission, followed by an 
indeterminate period of latency during which the virus continues to replicate, but at such 
low rates that the host immune system does not consider it a threat (Grinde, 2013). The 
latent virus can however still be transmitted through the shedding from the different 
mucosal layers and in the presence of suitable stimulants. It can also undergo reactivation 
to cause disease (Grinde, 2013). 
 The initial infection with HSV-1 occurs in the oral epithelium. The viral particles 
then are transported to the cell bodies of the trigeminal ganglia neurons from which they 
are transported to the trigeminal nerve and its branches (Bigley, 2014). This transport is 
enabled through alterations in the cytoskeletal components in neuronal and epithelial 
cells that occur in response to HSV-1 infection (Bigley, 2014). Specifically, IFN-γ 
produced by macrophages and other phagocytic cells up-regulates the expression of F-
actin (Bigley, 2014). F-actin is required for normal morphogenesis and development of 
neurons. In neuroblastoma cells, HSV-1 first increases and then decreases the levels of F-
actin, disrupting the cytoskeletal dynamic (Xiang et al, 2012). In response to HSV-1 
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infection, characteristic changes in the dynamic of biphasic F-actin were seen during the 
early and late phases (Xiang et al, 2012).  
First, when neuroblastoma cells in culture were infected with HSV-1, there was a 
progressive increase in stress fiber breakdown from 1 - 20 hours post infection (Xiang et 
al, 2012). Second, there was an increase in the outgrowth of dendritic filopodia and 
lamellipodia (neuritic extensions) from 1 – 20 hours post infection, after which it 
decreased (Xiang et al, 2012). Third, F-actin levels initially increased (from 2 – 6 hours 
post infection) and later decreased (6 – 20 hours post infection) (Xiang et al, 2012). 
When F-actin levels were experimentally decreased, viral entry was disrupted and it was 
noted that viral particles docked onto the neuritic extensions to enter the cell (Xiang et al, 
2012).  
 Since F-actin disassembly was observed between 2 – 12 hours post infection, 
regulators of F-actin dynamics like cofilin – 1 were analyzed (Xiang et al, 2012). The 
ratio of active cofilin – 1 to F-actin determines the assembled or disassembled state of the 
latter, with a high value resulting in F-actin nucleation and a low value resulting in 
fragmentation (Xiang et al, 2012). During initial stages of infection, levels of 
phosphorylated inactive cofilin – 1 decreased and active cofilin -1 increased. This trend 
reversed during the later stages of infection (Xiang et al, 2012). These results clearly 
show that F-actin dynamics in response to HSV-1 infection were regulated by cofilin – 1 
(Xiang et al, 2012). A decrease in cofilin – 1 led to the inability of HSV-1 to cause 
infection and its overexpression prevented HSV-1 intracellular replication in vitro (Xiang 
et al, 2012). 
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Once the virus located to in the neuronal cell bodies, the viral cells become 
transcriptionally silent except for a single gene that results in the formation of Latency 
Associated Transcripts (LATs) (Bigley, 2014). The primary LAT is 8.3 kb in size and is 
processed to a 1.5 – 2kb RNA which possesses significant cellular anti-apoptotic effects 
(Egan et al, 2013). While the LAT RNA contains eight open reading frames for 
translation, a LAT protein has not been observed in latent viral cells (Bigley, 2014; Egan 
et al, 2013). The LATs lead to the formation of about 17 microRNAs (miRNAs) and two 
small RNA (sRNAs) (Egan et al, 2013; Flores et al, 2013) that help maintain the latent 
state of the virus by inhibiting host cell apoptosis which is one of the mechanisms by 
which the host immune system clears viral cells (Egan et al, 2013). The anti-apoptotic 
effects of LAT are mediated by several mechanisms (Figure 2), including inhibition of 
granzyme mediated apoptosis in cytotoxic T lymphocytes, up-regulation of anti-apoptotic 
AKT and interaction with the death receptor and inhibition of caspase 8-mediated 
apoptosis (Egan et al, 2013). In addition, the miRNA produced from LAT causes 
inhibition of viral lytic factors including ICP0 and ICP4, thereby shifting the virus to take 
on a latent status (Egan et al, 2013). In the presence of physical and physiological stress 
like UV exposure or menstruation, hormones, such as glucocorticoids and progesterone, 
can cause a decline in the number of cytotoxic CD8+ T cells and IFN-γ which then leads 
to the up-regulation of the lytic phase of the viral infection cycle and viral reactivation 
(Figure 2) (Egan et al, 2013). 
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Figure 2. Overview of HSV-1 pathogenesis [No changes have been made. Adapted 
from Egan et al, 2013] 
 
Host Defense Responses to HSV-1 Infection: Role of Macrophages 
Host defense against HSV-1 infection is mediated primarily by macrophages, 
natural killer (NK) cells and cytokines (Erikksen, 2005). The antiviral response of NK 
cells (a type of CD8+ T cells) is governed by dendritic cells. Both macrophages and 
dendritic cells are capable of being infected with HSV-1, although through the secretion 
of a number of antiviral factors like IFN-γ and nitric oxide (NO), these cells prevent 
HSV-1 replication (Mott et al, 2009). To elucidate the underlying signaling mechanisms 
for macrophage and dendritic cell HSV-1 resistance, Mott et al (2009) compared the 
antiviral resistance of wild type murine macrophages with that of macrophages that were 
deficient in specific signaling molecules. They found that Signal Transducer and Activator 
of Transcription (STAT) protein is required for resistance to HSV-1 infection, and the 
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JAK-STAT pathway played a primary role in establishing antiviral resistance in 
macrophages and dendritic cells (Mott et al, 2009). 
The first line of defense for HSV-1 infection is the production of IFNα and IFNβ. 
Experiments have shown that exogenous supply of these cytokines to infected cells allow 
for a quick suppression of viral activities (Erikksen, 2005). Both infectious and UV-
inactivated HSV-1 can induce the production of IFN, although the former is more potent 
at this process (Erikksen, 2005). In human peripheral blood mononuclear cells (including 
macrophages), HSV gD induces the production of IFNα and IFNβ. The binding of the 
viral particles to pattern recognition receptors like TLR2 is necessary for progression of 
HSV induced encephalitis (Wang et al, 2011). Under in vivo conditions, dendritic cells 
use TLR9 for recognizing the viral antigens and induce the production of IFN via the 
MyD88 pathway (Wang et al, 2011; Gallego et al, 2011; Hochrein et al, 2004). IFNα 
synthesis depends on the tissue source (spleen, bone marrow and the like) of the dendritic 
or macrophage cells and can occur without TLR9 (Hochrein et al, 2004). The production 
of IFNα and IFNβ is regulated by a negative feedback mechanism via transcription 
factors IRF-3 and IRF-7, which are stimulated by high IFN levels (Xiaoyu et al, 2009; 
Erikksen, 2005). 
A possible mechanism by which macrophages generate a response against HSV-1 
is via the non-specific production of ROS (Erikksen, 2005). Certain triggers, such as 
exposure to phorbol esters, in the presence of viral antigens can activate macrophages to 
induce a respiratory burst with the help of the membrane bound NADPH oxidases that 
produce superoxide anions (O2-) and hydrogen peroxide. In the presence of IFNα and 
IFNβ and TNF, activated macrophages produce greater levels of ROS compared to 
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resting macrophages (Erikksen, 2005). The ROS produced lead to peroxidation of viral 
lipids during acute infection and suppress the apoptotic effect of HSV-1 (Erikksen, 2005). 
Another mechanism of antiviral activity of macrophages is by the production of 
nitric oxide (NO). Within 8 hours following viral infection, macrophages produce IFNα 
and IFNβ and TNFα. These signal via NFκB and induce the production of IL-12 from 8 
to about 24 hours following infection (Erikksen, 2005). After 24 hours, IL-12 induces the 
production of IFN-γ through a synergistic auto accelerating system (Erikksen, 2005). 
While IFNα, IFNβ and IL-12 activate STAT2 and STAT4, and thereby the JAK-STAT 
pathway, TNFα and IFN-γ activate transcription factors and NFκB and induce the 
synthesis of nitric oxide synthase (iNOS) (Erikksen, 2005). At the molecular level, 
activation of iNOS proceeds in a step-wise manner. First, IFN-γ stimulates STAT and 
indirectly aids in the expression of the transcription factor IRF-1. IRF-1, NFκB and 
activated STAT bind to their respective elements in the promoter region of the iNOS 
gene, aiding in its high expression (Erikksen, 2005).  
iNOS catalyzes the reaction of the oxidation of the guanidine nitrogen obtained 
from the conversion of L-arginine to L-citrulline to NO. The resulting NO mediates 
antiviral responses by restricting the generation of viral toxins, thereby protecting the 
surrounding host cells (Erikksen, 2005). IL-4 and IL-13 generally inhibit iNOS 
expression, but this inhibition is overcome following HSV-1 infection (Erikksen, 2005). 
The NO inhibitor N-monomethyl acetate disrupts response of macrophages infected with 
HSV-1 and produce HSV-1 induced corneal keratitis in a mouse model (Benencia & 
Courreges, 1999). 
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Role of Cluster of Differentiation (CD) Markers in HSV-1 Infection 
Cluster of Differentiation (CD) refers to the name given to cell surface antigens on white 
blood cells, which are recognized by a set of monoclonal antibodies (Janeway et al, 
2001). The significance of CD markers in host immunity, especially against viruses, may 
be seen during the initiation of viral infection. Viral antigens bind to cell surface 
receptors and often this single interaction is insufficient to generate an effective systemic 
antiviral response. T-cells usually contain a group of CD markers that function with the 
receptor to intercept the viral particles (for example, CD28 and CD80-86, and CD40 and 
CD154) (Edelmann & Wilson, 2000). These co-receptor molecules initiate a stronger 
interaction and response to the antigen, resulting in a signaling cascade and a much 
heightened immune response, enabling the host to completely eliminate the pathogen 
(Edelmann & Wilson, 2000). 
 Over 30 CD markers including CD4, CD80, CD163 and CD200 exist on 
macrophages (Janeway et al, 2001). CD80 also known as (B7.1), acts as the co-receptor 
for CD28 on T-cells and macrophages and is involved in mounting an inflammatory 
response to viral infection, and is expressed on B-cell subset (Edelmann & Wilson, 
2000). Edelmann & Wilson (2000) used a mouse model to show the role of these markers 
on the immune response to HSV-1. In mice, infection with HSV-1, if untreated, leads to 
systemic paralysis, which progresses to encephalitis and death (Edelmann & Wilson, 
2000). These authors found that the use of CTLA4Ig, which blocked the interaction of 
CD28/CD80 led to a destruction of the antiviral response of the host, leading to paralysis 
(Edelmann & Wilson, 2001). CD80 is considered a marker for M1 activated macrophages 
and another CD marker, CD163 is present on M2 activated macrophages. These can be 
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used to differentiate M1 and M2 macrophages in culture (Khramtsova et al, 2009). 
CD163 is a scavenger receptor and is up regulated during chronic infection by viruses 
like HIV (Burdo et al, 2011). Burdo et al (2011) found that with antiretroviral therapy, 
the titers of HIV decreased along with a mirrored reduction of CD163 levels.  
 CD200/CD200R are glycoproteins; the latter is expressed only on lymphoid 
lineage and myeloid cells. The interaction of the substrate and the receptor controls the 
function of myeloid cells (Gorczynski, 2012). Soberman et al (2012) analyzed the role of 
the anti-inflammatory CD200R/ CD200 interaction on macrophages and myeloid cells in 
HSV-1 infection. The authors found that CD200R1-/- mutant mice and macrophages were 
poor in supporting HSV-1 function showing that CD200R1 supported viral infection and 
replication and signaled via the TLR2 (Soberman et al, 2012; Wang et al, 2011). 
 The study of the effect of HSV-1 infection on host immune response has been 
studied using mouse models (Soberman et al, 2012; Stein & Falck-Pedersen, 2012; 
Edelman & Wilson, 2001), possibly due to the greater ease in maintaining mice under 
laboratory conditions and in the retrieval of peritoneal macrophages (Webre et al, 2012; 
Soberman et al, 2011; Cathcart et al, 2011). Other studies have used in vitro derived 
murine macrophage cell lines like RAW 264.7, J774A.1 and IC-21 (Stein & Falck-
Pedersen, 2012; Chamberlain et al, 2009). The RAW 264.7 cell line can be cultivated 
stably over a long-term under laboratory conditions and is a suitable substitute for 
Antigen Presenting Cells. This cell line is routinely used for immune studies (Stein & 
Falck-Pedersen, 2012). 
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 From Cheemarla’s study (2014), it is understood that CD86 is a specific M1 
macrophage cell-surface marker that promotes pro-inflammatory immune responses. 
Using M1 and M2 polarized murine macrophage cell lines, the mannose scavenger 
receptor CD206 did not distinguish between M1 and M2 phenotypes of human 
macrophages (data not shown). This study aimed to examine the morphology and 
viability of polarized macrophages, M1 activated by LPS/IFN-γ and M2 activated by 
each of IL-4, IL10, or IL-13, post HSV-1 infection at 18, 24, and 24 hours. It also 
examined the effect of HSV-1 infection on expression levels of CD80, CD163, and 
CD200R in M0, M1 and M2 macrophages at 18, 24, and 48 hours and compared them to 
uninfected polarized macrophages subpopulations. 
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Materials and Methods 
 
Cell Lines and Culture Conditions 
RAW 264.7 (American Type Culture Conditions, ATCC® TIB-71) is a murine 
macrophage cell line first induced in adult male BALB/C mice ascites following Abelson 
murine leukemia viral infection. These are adherent cells and cannot be grown in 
suspension. Frozen stocks of RAW 264.7 macrophages obtained from the manufacturer 
were thawed according to the instructions specified and cultured and maintained in 
100mm x 20mm culture petri plates (BD Biosciences) with Dulbecco’s Modified Eagle’s 
Medium (DMEM) (HyClone), 10% fetal bovine serum (heat-inactivated) (Fisher 
Scientific) and PSG (1% penicillin-streptomycin and 0.1% gentamycin, each at 
10000U/mL). Sub-culturing (1:6) was performed every two days.	  
 Vero 76 (ATCC® CCL-81TM) cells were used for their high virus susceptibility 
for growing, maintaining, and quantifying HSV-1 culture titers. Virus culture and 
quantification were conducted early in our lab to determine virus volume required for 0.1 
multiplicity of infection (MOI). Vero 76 cell line was cultured using manufacturer’s 
instructions (ATCC®). The frozen cell stock was thawed and grown in filter sterilized 
DMEM with 10% FBS (heat inactivated). The cells were sub-cultured 2-3 times to 
achieve maximum confluence and monolayers (Ammerman et al, 2008).	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Macrophage Polarization 
Polarization of the RAW 264.7 murine macrophage cell line to either the M1 or M2 state 
were performed using cytokines. Cells were grown to 50% confluence, incubated in a 
37°C  -humidified incubator supplied with 5% CO2, and treated for 18, 24, and 48 hours 
with 20ng/mL IFN-γ (Preprotech) and 100ng/mL of LPS (Chondrex) to induce the M1 
phenotype and with 20ng/mL of IL-4 (Peprotech), 10ng/mL of IL-10 (Peprotech) and 
10ng/mL of IL-13 (Peprotech) to induce the M2 phenotype. The cells were then 
harvested using Cell Stripper (Gibco), a non-enzymatic dissociating agent for adherent 
cells that can be used for longer periods of time than trypsin without damaging the cells. 
The harvested cells were maintained in growth medium and used for further analysis.  
Cell Viability 
At the time of sub-culture and growth for 24 - 48 hours, the RAW 264.7 macrophages 
were ~50% confluent. The cells were treated with cytokines to induce either M1 or M2 
cell state with or without 0.1 MOI HSV-1 infection. At three different time points 
following cytokine and virus addition (18 hours, 24 hours and 48 hours), cell viability 
was measured by staining the cells with trypan blue (Fisher Scientific) and using a 
hemocytometer to count live cells. 
Immunofluorescence Staining 
Cover slips (Fisher Scientific) were placed in 6 well cell culture plates. RAW 264.7 cells 
were grown on these cover slips to approximately 40% confluence. Treatment with IFN-γ 
and LPS for M1 activation and IL-4, IL-10 and IL-13 for M2 activation was performed as 
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described above and the cells incubated for 18, 24, and 48 hours with or without HSV-1. 
The supernatant was aspirated and the adherent cells were washed 3X with PBS 
containing 1% BSA. The adherent cells were fixed with PBS containing 4% 
paraformaldehyde for 15 minutes at room temperature. Following the aspiration of the 
fixing agent, the cells were blocked with 3% BSA in PBS for 1 hour to prevent non-
specific binding of the antibodies. The blocking buffer was removed and the cells were 
treated with Texas Red-Phalloidin X (3µL/million cells) against actin and the following 
fluorochrome-conjugated primary antibodies: anti-CD200R conjugated to Alexa Fluor 
488 (Antibodies-Online Inc.), anti-CD80 conjugated to Pacific blue (Biolegend) and anti-
CD163 conjugated to FITC (Antibodies-Online Inc.) (Table 1) or an appropriate isotype 
control antibody. They incubated overnight in the dark at 4˚C. Following antibody 
immunoreaction, cells were washed 3X with PBS containing 1% BSA to remove all 
unbound antibodies. Cover slips were then mounted for analysis on glass slides using 
VectaShield fluorescence mounting medium (Fisher Scientific) and visualized for 
immunofluorescence using the Olympus Epifluorescence microscop equipped with a 
“spot” digital camera. 
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Table 1. Summary of Antibody Concentrations for Immunofluorescent staining 
 
Antibody Concentration/Dilution 
 
Company 
 
Texas Red-Phalloidin X  (3µg/million cells) Life Technologies 
Alexa Fluor 488 conjugated 
anti-CD200R 
(0.5µg/million cells) Antibodies-Online Inc. 
Pacific blue conjugated anti- 
CD80  
(0.5µg/million cells) Biolegend 
FITC conjugated anti-CD163 (0.5µg/million cells) Antibodies-Online Inc. 
 
Flow Cytometry 
RAW264.7 cells were grown to confluence in petri plates (BD Bioscience) and were 
exposed to cytokines and LPS to activate either the classical pathway leading to M1 
phenotype or the alternate pathway leading to M2 phenotype with or without HSV-1 
infection for a period of 24 hours. The activating agents were removed and the cells were 
detached from the petri dishes and a sample was used for trypan blue staining and 
counted using a hemocytometer. The cells were washed 3X with PBS containing 1% 
BSA. The cells were then blocked with a solution of PBS containing 3% BSA and 5% 
serum from the species in which the antibody was generated for 1 hour. The blocking 
solution was removed and the cells were treated with fluorochrome-conjugated antibodies 
(FITC conjugated anti-CD200R (Biolegend), PE/Cy5 conjugated anti-mouse CD80 
(Biolegend), and FITC conjugated anti-CD163 (Antibodies-Online Inc.) (Table 2) or 
isotype control antibodies for respective antibodies diluted in blocking buffer for 1 hour 
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under dark conditions to prevent fluorescent bleaching. The cells were again centrifuged, 
the unbound primary antibodies removed and washed three times with PBS containing 
1% BSA. The cell pellet was re-suspended in sodium azide to preserve cell integrity and 
counted using the Accuri C6 flow cytometer. The number of M1 and M2 activated 
macrophages was determined based on the fluorescent-tagged antibody signals.  
Table 2. Summary of Antibody Concentrations for Flow Cytometry Assay 
Antibody Concentration/Dilution 
 
Company 
 
FITC conjugated anti-
CD200R 
(0.5µg/million cells) Biolegend 
PE/Cy5 conjugated anti-
mouse CD80 
(0.5µg/million cells) Biolegend 
FITC conjugated anti-CD163 (0.5µg/million cells) Antibodies-Online Inc. 
 
Statistical Analysis 
For statistical significance and graphical representations, we used Sigma Plot 12.5 
software. Students t test coupled with one-way ANOVA was used to detect statistical 
significance in the results obtained; p values < 0.05 were considered significant. 
Experiments in this study were conducted three times. 
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Results 
 
 Control and Polarized Macrophages before and after virus challenge 
Changes in macrophage morphology after polarization  
Macrophages were polarized into M1 and M2 phenotypes with LPS/IFN-γ or IL-
4, IL-10 or IL-13, respectively. Different cell morphologies were evident after HSV-1 
infection at 18, 24, and 48 hours. Stimulated M1 macrophages at 18 hours tended to be 
enlarged, flattened, adherent, and vacuolated (Figure 3). These morphological changes 
were more pronounced at 24 and 48 hours after polarization (Figures 4 and 5, 
respectively).  
Macrophages activated with IL-4, IL-10, or IL-13 were rounded compared to 
control cells at 18 hours (as best shown in Figure 3). At 24 and 48 hours of cytokines 
treatment, M2 macrophages were rounded compared to M0 (Figures 4 and 5 
respectively). However IL-10 polarized M2 macrophages showed few dendrites and 
some elongation at 48 hours (Figure 5). 
 
Cellular Morphology after HSV-1 challenge  
At 18 hours post-infection and polarization, HSV-1 infected M1 macrophages 
were strongly adherent (difficult to remove from plastic surfaces) and contained more 
vacuoles. In addition, they showed the same degree of elongation and dendrites as 
uninfected M1 cells (Figure 6). Infected and un-infected M1 macrophages exhibited the 
same morphology after 24 and 48 hours of treatment and infection (Figures 7 and 8, 
respectively).  
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M2 macrophages activated by IL-4,10,or 13 appeared to be rounded after 18 
hours of virus challenge compared to uninfected M2 macrophages (Figure 6). The same 
results were observed at 24 and 48 hours after infection and polarization (Figures 7 and 8, 
respectively). However, M2 macrophages polarized by IL-10 showed some elongation 
after 48 hours of viral infection (Figure 8).  
 
Measuring Cell Viability / Cytotoxicity 
 
Determination the number of viable cells for un-polarized and polarized 
macrophages before and after virus challenge at three time points 
Cytotoxicity studies were performed for untreated control macrophages (i.e., “un-
polarized”) and treated polarized macrophages at 18, 24, and 48 hours using trypan blue 
stain. Results were statistically evaluated 5x105 viable cells from three separate 
experiments. At 18 hours post-polarization, both activated M1 macrophages and activated 
M2 macrophages induced with IL-4, IL-10, or IL-13 showed statistically significant 
decreases (P-values of 0.001 and <0.001, respectively) in viable cells when compared to 
control untreated macrophages (data not shown). M1 and IL-13-activated M2 
macrophages exhibited significant decreases in viable cells (P-value ≤0.005 and 0.011, 
respectively) when compared to M0 macrophages after 24 hours of cytokine treatment 
(Figure 9). The greater decreases in cell viability were seen in the M1 population. The 
results were not statistically significant for M2 macrophages activated with IL-4 and IL-
10 after 24 hours of polarization compared to untreated macrophages. 
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Post -infection with HSV-1: 
HSV-1 infected macrophages showed a greater loss in cell viability in comparison 
to un-infected macrophages at 24 hours in Cheemarla’s study (2014). In this study, the cell 
viability assay using trypan blue showed that at 18 hours after polarization and viral 
infection, infected M1 macrophages and infected M2 macrophages activated by IL-4 
exhibited significant decreases in viable cells when compared to un-infected control M0 
(P-value<0.04 for both).  Conversely, un-infected M2 macrophages activated by IL-13 
showed a statistically significant decrease in viable cells when compared to infected 
control macrophages (P-value <0.05). No significant differences were observed among 
other uninfected and infected subpopulations (data not shown).  
At 24 hours post-infection, infected M1 and M2 macrophages activated by IL-13 
showed significant decreases in viable cells in comparison with infected controls (P-value 
≤0.05 and 0.01, respectively) (Figure 10). There was a significant decrease in viable cells 
among HSV-1 infected macrophages after 48 hours of infection. Infected M1 
macrophages showed significant decreases in cell viability compared to infected M0 
controls. Compared to infected M1 macrophages, infected M2 macrophages polarized by 
IL-4, IL-10, or IL-13 displayed higher cell viabilities (P- value <0.001, ≤0.005, ≤0.002, 
≤0.005, respectively) (Figure 11).  
 
Analysis of CD Marker Expression on Control and Polarized Macrophages Pre and 
Post HSV-1 infection 
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Evaluation of CD marker expression of macrophage phenotypes at 18, 24, and 48 
hours after cytokine treatment and HSV-1 infection 
Immunofluorescence staining was performed to analyze the expression of CD80, 
CD163, and CD200R on un-polarized and polarized macrophages at 18, 24, and 48 hours 
after cytokine activation and HSV-1 infection. CD80 expression was up regulated at 18 
hours in M1 macrophages and M2 activated with IL-4 macrophages compared to M0 
control macrophages and M2 activated with IL-10 and IL-13. After 24 hours of treatment, 
no difference was found in the expression of CD80 among polarized and control 
macrophages. M1 macrophages showed increased expression of CD80 after 48 hours post 
polarization (Supplemental figure 1). Down-regulation of CD80 expression was found at 
18 hours in M1 macrophages and IL-4 induced M2 macrophages after HSV-1 infection in 
comparison to uninfected ones. At 24 and 48 hours, there was no significant difference in 
CD80 expression among infected and uninfected macrophages (Supplemental Figure 2).  
CD163 was expressed regularly on control and polarized macrophages at 18 and 
48 hours. M1 macrophages and M2 macrophages induced by IL-4 showed higher 
expression of CD163 at 24 hours after activation (Supplemental Figure 3). No observable 
differences in CD163 were shown in virus infected M0, M1, and M2 macrophages 
activated with IL-4, IL-10, and IL-13 when compared to non-infected cells at 18 and 48 
hours. There were higher, but statistically insignificant, differences in virus-infected M2 
macrophages induced by IL-10 after 24 hours post-infection compared to uninfected 
counterpart (Supplemental Figure 4).  
M1 macrophages polarized by LPS/IFN-γ and M2 macrophages polarized by IL-4 
exhibited higher levels of CD200R expression at 18 hours of polarization compared with 
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M0 and M2 macrophages activated by IL-10 and IL-13. At 48 hours, CD200R expression 
was found to be higher in IL-10-induced M2 macrophages. CD200R expression was 
minimal or steady on untreated and treated macrophages at 24 hours (Supplemental 
figure 5). Control M0 and M1 macrophages showed the same expression of CD200R 
before and upon HSV-1 infection as shown in immunofluorescent images at 18 hours. 
However, infected M2 macrophages induced by IL-4 showed down-regulation, or no 
expression, of CD200R at the same time. IL-10 and IL-13 activated M2 macrophages 
exhibited very low numbers of CD200R+ cells upon 18 hours of viral infection.  
Immunofluorescent images did not show any differences in number of CD200R+ cells 
among infected and uninfected macrophages at 24 hours after infection and polarization. 
At 48 hours, the same level of CD200R expression was shown among infected and 
uninfected M2 macrophages induced by IL-10 and IL-13 while M1 and M2 macrophages 
activated with IL-4 showed more expression after virus infection in comparison to 
uninfected cells (Supplemental Figure 6). Overall, immunofluorescence assays revealed 
the expression of CD80, 163, and 200R at varying levels on cytokine-treated and non-
treated macrophages after virus challenge however it was difficult to detect the exact 
expression levels of each CD markers using this method (Data shown in appendix). 
Flow cytometric analysis was conducted at 24 hours of polarization and CD 
marker profiles for uninfected and HSV-1 infected and polarized macrophages revealed 
that both macrophage phenotypes expressed CD80, 163, and 200R at different levels 
before and after viral infection. Compared to untreated control macrophages whose 
CD80+ population was 26.72%, the CD80+ portion of the population was slightly 
decreased for uninfected polarized M1 (18.72%) and M2 macrophages (19.50% and 
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21.29% for IL-10- or IL-13-induced M2 macrophages, respectively). Conversely, M2 
macrophages activated by IL-4 demonstrated an increase in the expression level of CD80 
(to 32.00%) compared to M0 (Figures 12A and B). Infected M1 macrophages (20.20%), 
IL-4 (25.60%) and IL-13 (23.80%) induced M2 macrophages showed slight decreases in 
CD80 + cells in compared to infected un-polarized control M0 (30.24%). On the other 
hand, the level of CD80 expression was the same in both HSV-1 infected M2 
macrophages activated by IL-10 and M0 (30.27% and 30.24%, respectively) (Figures 
13A and B). There was a slight increase in CD80+ of M1 macrophages (20.20%) and M2 
macrophages induced by IL-10 (30.27%) and IL-13 (23.80%) after viral infection when 
compared to their uninfected counterparts (18.72%, 19.50%, and 21.29%, respectively). 
In contrast, IL-4 induced M2 macrophages showed down-regulation of CD80 expression 
after infection (25.60%) in comparison to M2 macrophages induced by IL-4 (32.00%) 
before viral challenge (Figure 13C). None of these findings were found to be statically 
significant using one-way ANOVA and t-tests. 
The expression of CD163 was up regulated in uninfected M1 macrophages and 
IL-4-induced M2 macrophages to 12.96% and 10.45%, respectively, compared to M0 
macrophages with only 6.69% of cells expressing CD163. However, M2 macrophages 
activated by IL-10 (7.40%) and IL-13 (7.00%) showed no changes in CD163+ cells when 
compared with control macrophages (6.69%) (Figures 14A and B).  
Infected M1 macrophages displayed down-regulation of CD163 expression to 4.94% 
compared to infected un-polarized M0 macrophages (7.31%). Infected M2 macrophages, 
which were polarized by IL-4 (7.74%) and IL-13 (6.69%), showed no change in CD163 
expression when compared to control. However, the expression of CD163 increased in 
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IL-10 activated M2 macrophages to 9.29% after viral infection compared with infected 
M0 macrophages (Figures 15A and B). Down-regulation was observed in CD163 
expression on M1 macrophages (4.94%) and IL-4 activated M2 macrophages (7.74%) 
upon infection, compared with uninfected M1 macrophages (12.96%) and M2 
macrophages induced by IL-4 (10.45%). An increase was observed for M2 macrophages 
activated with IL-10 (9.29%) after HSV-1 infection compared to uninfected M2 
macrophages induced with IL-10 (7.4%) (Figure 15C). 
Uninfected M1 and M2 macrophages induced by IL-10 or IL-13 showed 
insignificant changes in CD200R expression (7.30%, 6.70%, and 7.23%, respectively) 
compared to M0 macrophages (8.98%). However, M2 macrophages polarized by IL-4 
exhibited an insignificant increase in CD200R expression to 11.81% when compared to 
untreated control (8.98%) (Figure16). 
CD200R expression was slightly less in M2 macrophages polarized by IL-4 after 
infection compared to infected controls at 10.34% and 11.33%, respectively. Expression 
was down regulated significantly in infected M1 macrophages (5.48%; P-values <0.001 
and <0.005) compared to infected M2 macrophages activated with IL-4 (10.34%) and IL-
10 (9.84%), respectively. Infected M1 macrophages displayed a low population of 
CD200R+ cells (5.48%) after viral infection compared to infected controls (11.33%). 
CD200R expression was down regulated insignificantly in M2 activated by IL-10 
(9.84%), and IL-13 (9.98%) after HSV-1 infection compared to infected M0 
macrophages (11.33%) (Figures 17 A and B). Infected M1 macrophages (5.48%) and M2 
macrophages induced by IL-4 (10.34%) expressed less CD200R+ in comparison to their 
uninfected counterparts (7.30% and 11.81%), respectively. However, infected M2 
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macrophages induced by IL-10 and IL-13 displayed higher number of CD200R+ (9.84% 
and 9.98%, respectively) than uninfected M2 macrophages induced by IL-10 (6.70%) and 
IL-13 (7.23%) (Figure 17C).  Despite the differences in CD marker expression among 
virus-infected macrophages and uninfected cells, these differences were not statistically 
significant as shown by one-way ANOVA test coupled with t-test for three independent 
experiments. 
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Discussion 
 
The present study attempted to determine the differences in morphology and 
distribution of cell surface markers CD80, CD163 and CD200R on polarized and un-
polarized macrophages before and after HSV-1 infection to compare the study of 
Cheemarla (2014). Polarization and activation of macrophages were performed using 
LPS/IFN-γ to induce M1 macrophages and IL-4, IL-10, or IL-13 to induce M2 
macrophages. Activation to M1 and M2 phenotypes resulted in alterations in morphology 
at 18, 24 and 48 hours. Polarized M1 were elongated, vacuolated and strongly adherent. 
However, polarized M2 macrophages were rounded and similar to untreated 
macrophages. M1 macrophages also showed a great decrease in cell viability compared 
to control and M2 macrophages. 
Following viral infection, the morphological changes seen in M1, IL-4, IL-10, and 
IL-13 activated M2 cells were similar to those seen in uninfected polarized cells. 
However, 48 hours post viral infection, IL-10 activated M2 cells showed mostly rounded 
cells with some elongation, as visually monitored, compared with IL-4 or IL-13 activated 
M2 or control cells. The similarities in morphological changes following viral infection 
have also been noted for other pathogenic agents like Cryptococcus neoformans (Davis et 
al., 2013). The authors attributed these similarities to the factors produced by the 
invading pathogen (Davis et al., 2013).  
Cytotoxicity assays showed that there was a statistically significant increase in 
cell mortality among all macrophage types at 18 hours post activation, when compared to 
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un-polarized M0 cells. At 24 hours post activation, M1 and IL-13 activated M2 cells 
continued to show higher cell mortality compared to IL-10 or IL-13 activated M2 and M0 
cells. The difference became insignificant at 48 hours. Cell mortality trends can be 
explained by the type of cytokine produced by each macrophage cell type. For example, 
IFN-γ activated M1 cells generate TNFα, which is a pro-inflammatory cytokine with high 
cytotoxicity. IL-10 is produced by activated M2 cells, this anti-inflammatory cytokine 
may aid in cell protection (Singh et al., 2011). Measuring the levels of inducible nitric 
oxide synthase (iNOS) produced in each cell culture (M1 and M2) and comparing with 
the control (M0) using Griess reagent as suggested by Lifshitz et al., (2010) could 
provide a clearer quantification of the cell cytotoxic response of the cytokines. The 
duration of cytokine production has also been shown to initially increase and then decline 
due to an adaptation of the cells to their surrounding (Bartneck et al., 2013) and this 
observation corroborates the existing findings. 
Viable cells were significantly reduced in infected M1 and IL-13 activated M2 
macrophages at 24 and in infected M1 at 48 hours after infection. This reduction is 
possibly due to the response of these cells to viral infection. IFN-γ activated M1 cells 
infected with HSV-1 generate an inflammatory response (Edelmann & Wilson, 2000), 
which culminates in cytotoxicity.  
For determining the expression of cell surface markers CD80, CD163 and 
CD200R, immunofluorescence staining was performed on polarized and un-polarized 
macrophages at 18, 24 and 48 hours. Non-activated M0 macrophages were used as 
controls for comparison.	  In M1 macrophages (activated by LPS/IFN-γ) and M2 
macrophages (activated by IL-4), the expression of CD80 was up regulated until 24 hours 
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post activation, and this level was much higher than in M2 macrophages (activated by IL-
10 or IL-13) and control M0 cells. After 24 hours, the levels of CD80 quickly reduced to 
reach control levels by 48 hours post activation.	  The higher levels of CD80 expression by 
M1 macrophages compared to controls are possibly due to their pro-inflammatory nature, 
as suggested by Mantovani (2006).	  IFN-γ has been shown to induce an increase in 
expression of CD80 during the first 24 hours after activation in monocytes through their 
involvement in CD28 pathway mediated amplification of T cells via the interferon 
regulatory factor – 1 protein (IRF1) (Freedman et al., 1991; Bauvois et al., 2009).	  The 
increase in IL-4 induced CD80 expression (much lower than that induced by LPS/IFN-γ) 
has also been validated by Ambarus et al. (2012) who used qPCR to quantitate these 
markers in macrophages. CD80 was down regulated at 18 hours post activation/ viral 
entry in HSV-1 infected cells compared to non-infected cells.	  CD80 has been shown to be 
associated with the pro-inflammatory functions of M1 macrophages and changes in their 
numbers on the cell surface can be attributed to the fluctuations in the inflammatory 
response of the cells in vitro to viral entry (Edelmann & Wilson, 2000). 
	   In the case of the marker CD163, the current experiments showed M1 and M2 
cells (IL-4 activated) had the highest expression at 24 hours post activation, while the 
levels of this marker on M2 (IL-10 and IL-13 activated) were not significantly different 
from the M0 controls. CD163 levels showed no statistically significant changes in 
number before and after viral entry for all macrophage cell types at 18, 24 and 48 hours 
post activation/ viral entry. However, there was higher CD163 expression noted, although 
not statistically significant, in virus-infected M2 macrophages induced by IL-10 after 24 
hours post-viral entry compared to uninfected M2 macrophages induced by IL-10. 
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Ambarus et al., (2012) showed that CD163 expression was highest in IL-10 activated M2 
cells while M1 and M2 (IL-4 activated) were similar to controls. The difference in this 
expression profile could be accounted by the differences in study design, the type of cells 
used for culture and the amount of the activating cytokine used (Ambarus et al., 2012). 
	   The levels of CD200R marker were found to be highest in M1 and IL-4 activated 
M2 cells at 18 hours post activation while the other cells showed similar control level 
expression of this marker. As shown by immunofluorescence assay CD200R was 
unchanged at all time points in all cell types.  
The use of flow cytometry however showed some differences that 
immunofluorescence failed to detect. Firstly, the levels of CD80 on HSV-1 infected M1 
and M2 cells were lower than HSV-1 infected un-polarized M0 cells. The down-
regulation of CD80 expression in infected M1 macrophages can again be explained by 
the pro-inflammatory functions associated with this cell surface marker (Edelmann & 
Wilson, 2000).	  The baseline expression of this marker in IL-10 activated M2 cells could 
be credited to the anti-inflammatory nature of this cytokine (Singh et al., 2011). The 
fluctuations in CD80+ cells were not statistically significant.	  
	   CD163 is a scavenger receptor and its expression varies significantly on 
macrophage types – its expression is generally low on un-polarized monocytes and 
increases upon activation (Welch & Calvert, 2010). In the presence of IFN-γ, the levels 
of this marker have been shown to be down regulated (Welch & Calvert, 2010). In 
addition, oxidative stress induced by nitric oxide has been shown to cause CD163 
shedding from monocytes (Timmerman & Hogger, 2005). This phenomenon could 
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explain the down-regulation of CD163 expression detected on M1 cells following HSV-1 
infection in this study. On the other hand, the expression of CD163 has been known to 
increase in the presence of IL-10 (Welch & Calvert, 2010). The up-regulation of CD163 
expression after infection could have been due to a greater response to a pathogenic 
antigen compared to non-pathogenic conditions. Additionally, this observation confirmed 
the fact that CD163 was found to be a specific marker for M2 macrophages induced by 
IL-10 (Ambarus et al., 2012). In this study, IL-10 activated M2 cells after HSV-1 
infection showed increased expression of CD163 compared to IL-10 activated M2 cells 
without HSV-1 infection. In 3-separate experiments of flow cytometry, ANOVA showed 
no significance among the polarized cell populations (M1 or M2). 
	   CD200R, when complexed with its ligand CD200, brings about anti-inflammatory 
responses and down-regulates production of pro-inflammatory cytokines (Sarangi et al., 
2009).	  The down-regulation of CD200R seen on M1 cells post viral infection could have 
been due to the cell’s activation of inflammatory pathways and reduction of anti-
inflammatory responses.	  Since the generation of an inflammatory response is a primary 
defense mechanism for viral infection, the low level of CD200R in HSV-1 infected cells 
could have been the cell’s way of preventing an anti-inflammatory response in the 
presence of the virus. IL-4 and IL-10, but not IL-13, activated M2 cells. These cytokines, 
being anti-inflammatory by nature, have resulted in significant increases in CD200R 
expression after viral infection compared to infected M1 macrophages. This result has 
been corroborated by Ambarus et al. (2012) who showed IL-4 mediated activation 
selectively up-regulated CD200R expression in macrophages. In the present study, RAW 
264.7 macrophages polarized to the M2 phenotype with IL-4 or IL-10 showed 
	  
	   38	  
significantly greater expression of CD200R than did the M1 polarized cells. This result 
was similar to that found in a recent study by Jaguin and colleagues (2013). They used 
monocytes purified from human peripheral blood cells to characterize phenotypic and 
genomic markers. First, they generated macrophages from these primary human cells by 
treatment with M-CSF and polarized them using the same inducers used in the present 
study, LPS/IFN-γ to induce M1 phenotype and IL-4 to induce the M2 phenotype. They 
found that CD80 (B7.1) was unique to M1 phenotype and CD200R was unique to the M2 
polarized human macrophages. These observations were similar to the findings in the 
present study and the study done by Cheemarla (2014). The primary difference between 
Jaguin et al. and the present and former study by Cheemarla is that the latter two studies 
used murine macrophages (RAW264.7) and polarized them into M1 by using IFN-γ and 
LPS, while IL-4 was used for polarization of the M2 phenotype. Similar to the 
observations of Cheemarla (2014) with CD86, the expression of CD80 in the present 
study was unique to polarized M1 populations. Cheemarla (2014) did not observe a 
difference in expression of CD206 between M1 and M2 polarized murine macrophage 
cell lines (data not shown). Similarly, Jaguin et al (2013) found the mannose receptor 
CD206 did not distinguish between M1 and M2 phenotypes of human macrophages. In 
the present study, there was no significant difference in expression of scavenger receptor 
CD163 between the M1 and M2 polarized RAW 264.7 cells (Table 3). 
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Table 3. Summary of CD markers studied by Cheemarla and this study. 
Monocyte/Macrophage Markers 
 
Scavenger Receptors 
 
Membrane Glycoprotein 
 
CD14- LPS receptors 
 
CD206 macrophage mannose 
receptor (MMR) 
 
CD200R- expressed mainly on 
monocytes and neutrophils. 
Interaction between CD200R and 
CD200 limit and suppress 
macrophage-induced inflammatory 
damage. 
CD80 (B7.1) co-receptor on antigen –
presenting cells (APCs) 
 
CD163- hemoglobin-
haptoglobin receptor; 
expressed on both monocytes 
and macrophages 
 
CD86 (B7.2) co-receptor on APCs   
 
The present study showed that changes in macrophage morphology and viability 
occur following activation by cytokines with or without HSV-1 infection. Also, the 
expression levels of cell surface markers CD80, CD163 and CD200R are altered under 
these conditions. M1 cells were swollen, elongated, vacuolated and strongly adherent 
before and after viral infection.  In addition, cell viability is significantly decreased in M1 
populations upon viral infection compared to control and M2 macrophages, possibly as a 
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result of production of cytotoxic molecules. The down-regulation of CD80 expression 
post-infection in M1 macrophages, albeit not statistically significant, suggested that it is a 
specific M1 macrophage cell-surface thus promoting pro-inflammatory immune 
responses. CD163 expression was found in both phenotypes M1 and M2 macrophages; 
however, increased expression was observed in IL-10 polarized M2 cells after viral 
infection, although this increase was not found to be statistically significant. CD200R 
expression was significantly higher in M2 macrophages compared with the M1 
phenotype. One possible reason for this effect may be that higher expression of CD200R 
might serve to block the pro-inflammatory pathway.  
This study was significant given that macrophage subtypes have been associated 
with diseases including cancer and pneumonia, and manipulation of the presently studied 
cell surface markers have been found to have therapeutic value for alleviating these 
conditions to some extent (Davis et al., 2013; Singh et al., 2011). Macrophages play 
pivotal roles in tumor growth and metastasis and they participate in immune responses to 
tumors in a polarized manner.  M1 macrophages produce IL- 12 to promote tumoricidal 
responses, whereas M2 macrophages help tumor progression. Thus the overall survival 
and the immune response to tumors may be improved by converting the M2 phenotype 
macrophage in solid tumors to an inflammatory M1 phenotype. 
Manipulating CD200R interaction with its ligand CD200 has therapeutic potential 
for many diseases; therefore further studies would be beneficial. Since murine and human 
macrophages showed similarity in specifically inducing CD200R expression in M2 
macrophages, studies should be carried out using animal models of human disease to 
explore the requirement for M1 or M2 over the other in specific disease states. For 
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example, certain neurological disorders such as Alzheimers disease and Multiple 
Sclerosis have shown the potential for better outcomes when M2 macrophages expressing 
CD200R are more prevalent than M1 macrophages (Walker & Lue, 2013). Conversely, in 
HSV-1 infection, M1 macrophages are more effective at controlling viral replication than 
M2 macrophages. An in vivo animal model of HSV-1 infection can further delineate the 
actions of M1 and M2 macrophages, and the role of CD200R. Experimental animals can 
be injected with 0.1 MOI HSV-1, followed by evaluation of M1 versus M2 macrophage 
populations, as well as the prevalence of CD200R in splenic macrophages by flow 
cytometry. To determine the role of CD200R in blocking the polarization of macrophages 
to the M1 state, a CD200R -/- knockout mouse model can be used. Comparison of M1 
versus M2 populations in both wild-type and the knockout mice would reveal CD200R’s 
contribution towards controlling induction of M1 macrophages. We would expect that the 
CD200R -/- animal model would display an increase in the M1 macrophage population 
compared to wild-type and this would promote an inflammatory state that should be 
observable in the mice. 
An in vitro approach to assess the role of CD200R can include blocking CD200R 
on RAW264.7 cells using anti-mouse CD200R mAb. After blocking CD200R, cytokine 
production (i.e., pro- versus anti-inflammatory) can be measured in culture supernatants 
using enzyme-linked immunosorbent assay (ELISA). Alternatively, the role of CD200R 
can be titrated using different amounts of small interfering RNAs to reduce the 
expression of CD200R to varying levels. With both of these techniques, it is anticipated 
that the level of pro-inflammatory cytokines will be greater in cultures with reduced 
CD200R expression/function compared to control cells. 
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Further studies should also be conducted to more accurately follow morphological 
changes in macrophages for better understanding the differences between M1 and M2 
based on their morphology. More accurate methods should be employed over the visual 
observations that may be considered subjective. The use of the Quartz Crystal Micro- 
balance with Dissipation monitoring technology (QCM-D) combined with light 
microscopy has shown to track morphological changes in NI- H3T3 fibroblasts and 
human derived fibroblasts (Tymchenko et al., 2012). It enables one to measure more data 
points per second and analyze the mechanical properties at the cell-surface interface. The 
sensors of QCM-D are coated with silicon dioxide and functionalized with collagen I to 
act as a cell adhesive layer through binding to integrin receptors on the surface of the 
cells. The technique uses a Q-Sense E1 chamber equipped with a Q-Sense Window 
Module mounted on a Leica DM4000M microscope. The experiment is performed by 
seeding cells on the coated sensor to be attached, and following their responses in real-
time (Tymchenko et al., 2012). 
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Figure 3. Changes in morphology of RAW 264.7 macrophage sub-populations 18 
hours after polarization. A-E showed macrophages after staining with phalloidin for 
actin arrangement. A showed un-polarized control (M0), B, polarized M1 
macrophages by LPS and IFN-γ, and C- F showed polarized M2 macrophages by IL-
4, IL-10, and IL-13 respectively. As appeared at 18 hours post treatment M1 were 
elongated, and started forming intracellular vacuoles. IL-4, 10,and 13 treated 
macrophages (M2) are rounded and displayed no changes in morphology as 
compared to control macrophages. (Scale bar =50µm). 
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Figure 4. Changes in morphology of RAW 264.7 macrophage sub-populations 24 
hours after polarization. A-E showed macrophages after staining with phalloidin for 
actin arrangement. Morphological changes exhibited by polarized M1 macrophages. B 
showed more cytosolic vacuoles were formed after 24 hours of treatment and became 
more elongated, flatten, and dendrites. M2 macrophages 24 hours post cytokines 
treatment in C-E. M2 macrophages induced by IL-4, 10, and 13 are rounded and no 
visible changes in morphology as compared to control macrophages. (Scale bar =50µm). 
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Figure 5. Changes in morphology of RAW 264.7 macrophage sub-populations 48 
hours after polarization. A-E showed macrophages after staining with phalloidin for 
actin arrangement. M1 macrophages in B showed more elongation and formed much 
more of cytosolic vacuoles and became strongly adherent after 48 hours of cytokines 
treatment. M2 macrophages sub-populations exhibited the same morphology as 
macrophages treated for 24 hours except for IL-10 induced macrophages that showed 
elongation state at 48 hours of polarization. (Scale bar =50µm). 
M0 
A M2/IL-4 C
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Figure 6. RAW 264.7 macrophages morphology 18 hours post HSV-1infection. A 
represented HSV-1 infected control cells M0. B represented polarized M1 after HSV-1 
infection. HSV-1 infected M1 macrophages showed strong adhesion state and had more 
vacuoles. In addition, they showed the same degree of dendrites as uninfected M1. C-E 
showed M2 stimulated by IL-4, IL-10, and IL-13 respectively after HSV-1 infection. M2 
macrophages appeared to be rounded after virus challenge as same as uninfected M2 
macrophages. (Scale bar =50µm). 
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Figure 7. Morphological changes of RAW 264.7 macrophages after 24 hours of 
HSV-1 infection. B showed infected M1 appeared highly vacuolated and elongated as 
same as uninfected M1 at 24 hours of infection. C-E showed infected M2 macrophages 
after 24 hours of viral infection. They are rounded and few M2 macrophages appeared 
enlarged compared to control as well as uninfected control and M2 cells. (Scale bar 
=50µm). 
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Figure 8. Cell shapes of RAW 264.7 macrophages 48 hours after virus infection. 
Infected M1 macrophages became highly vacuolated, elongated and strongly adherent as 
well as uninfected M1 at 48 hours. M2 macrophages activated with IL-4 and IL-13 are 
rounded and showed the same morphology as compared to infected control. IL-10 
activated macrophages showed higher degree of elongation at 48 hours post-infection 
than 18 and 24 hours after virus challenge. (Scale bar =50µm). 
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Figure 9. Viable cells that remaining after 24 hours of cytokine treatment before 
HSV-1 infection. Uninfected M1 and IL-13 activated M2 macrophages exhibited 
significant decreases in viable cells (P-value ≤ 0.005, 0.011), respectively, when 
compared to untreated control M0 macrophages at 24 hours. However M2 activated with 
cytokines IL-4 and IL-10 showing no significant difference in their viability after 24 
hours comparing to untreated macrophages. The starting population of cells for each 
condition was 5x105. Error bars represent standard error. A representative experiment (of 
three trials) is shown. 
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Figure 10: Viable cells remaining after 24 hours of cytokines treatment and post 
HSV-1 infection. Infected M1 and M2 cells activated by IL-13 showed significant 
decreases (P-value ≤ 0.05, 0.01 respectively), in compared with infected controls. The 
starting population of cells for each condition was 5x105. Error bars represent standard 
error. A representative experiment (of three trials) is shown. 
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Figure 11. Viable cells remaining at 48 hours of cytokine activation before and after 
HSV-1 infection. No statically significant differences found among un-polarized and 
polarized macrophages. However, a significant decrease in viable cells observed among 
HSV-1 infected macrophages at 48 hours of infection. Infected M1 (P- value <0.001) (P- 
value ≤ 0.005, 0.002, 0.005) showed significant decreases in viable cells when compared 
to infected control and infected M2 polarized by IL-4, IL-10, and IL-13, respectively. The 
starting population of cells for each condition was 5x105. Error bars represent standard 
error. A representative experiment (of three trials) is shown. 
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Figure 12 A. CD80 expression profiles in untreated control and polarized macrophage 
phenotypes after 24 hours of stimulation. Flow cytometry analysis of CD80 was performed at 
24 hours using negative isotype control for CD80 antibodies to set experiment quadrants. M1 
macrophages and M2 macrophages induced by IL-10 and IL-13 showed a decrease number of 
CD80+ cells (18.72%, 19.50%, and 21.29% respectively). However IL-4 activated M2 had up to 
(32.00%) CD80 positive cells when compared to untreated controls (26.72%).  
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Figure 12 B. Levels of CD80 expression in untreated control M0 and polarized M1 
and M2 before HSV-1 infection. No significant differences in CD80 expression were 
shown among macrophages. The experiments were done in triplicate. 
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Figure 13 A. CD80 expression profiles in HSV-1 infected macrophage phenotypes at 
24 hours. Data are presented by flow cytometric assay for HSV-1 infected and polarized 
macrophages. Infected M1 (20.20%), IL-4 (25.6%) and IL-13 (23.80%) induced M2 cells 
showed slight decrease in CD80 expression in comparison to infected un-polarized 
control M0 (30.24%). The level of CD80 expression was the same in both HSV-1 
infected M2 cells activated by IL-10 and M0 (30.27% and 30.24%, respectively). None 
of these findings was found to be statically significant using one -way ANOVA and t-
tests.  
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Figure 13 B. CD80 expression levels in viral infected macrophages at 24 hours. No 
significant differences in CD80 expression were shown among infected macrophages. A 
representative experiment (of three trials) is shown. 
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Figure 13 C.  Expression profiles of CD80 in uninfected and infected macrophages 
at 24 hours. Data are presented by flow cytometric assay for HSV-1 infected and 
uninfected macrophages. Infected M1 (20.20%), IL-4 (25.60%) and IL-13 (23.80%) 
induced M2 macrophages showed decreases in CD80 expression compared to infected 
un-polarized controls M0 (30.24%). The level of CD80 expression was the same in both 
HSV-1 infected M2 macrophages activated by IL-10 and M0 (30.27% and 30.24%, 
respectively). There was a slight increase in CD80+ number in M1 (20.20%) and M2 
induced by IL-10 (30.27%) and IL-13 (23.80%) after viral infection when compared to 
their uninfected counterparts (18.72%), (19.50%), and (21.29%), respectively. In 
contrast, IL-4 induced M2 macrophages (25.60%) showed down regulation of CD80 
expression after infection compared to M2 macrophages induced by IL-4 (32.00%) 
before virus challenge. None of these findings were found to be statistically significant 
using one-way ANOVA and t-tests. The experiments were done in triplicate 
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Figure 14 A. CD163 expression profiles in untreated control and polarized 
macrophage phenotypes after 24 hours of polarization. CD163 expression shown by 
flow cytometry analysis using negative isotypes control CD163 antibodies to set 
experiment quadrants. Higher levels of CD163 expression were expressed by M1 
macrophages and macrophages induced by IL-4 (12.96% and 10.45%, respectively) 
compared to M0 macrophages (6.69%). No differences were observed in CD163 
expression in M2 macrophages activated by IL-10 (7.40%) and IL-13 (7.00%) in 
comparison to untreated controls.  
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Figure 14 B. CD163 expression level in uninfected macrophages at 24 hours of 
treatment. No significant differences in CD163 expression were shown among 
macrophages subpopulations. The experiments were done three times. 
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Figure 15A. CD163 expression levels in HSV-1 infected macrophages after 24 hours 
of infection. Infected M1 displayed down-regulation in CD163 expression (4.94%) 
compared to infected un-polarized M0 (7.31%). Infected M2 macrophages polarized by 
IL-4 (7.74%) and IL-13 (6.69%) showed no change in CD163 expression when compared 
to control. However, the expression of CD163 was increased in IL-10 activated M2 cells 
(9.29%) after virus infection compared to infected M0. 
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Figure 15 B. Expression of CD163 in viral infected macrophages at 24 hours. No 
significant differences in CD163 expression were shown among infected macrophages 
subpopulations. The experiments were done in triplicate. 
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Figure 15 C. Expression of CD163 in viral infected macrophages and uninfected at 
24 hours. Infected M1 displayed down-regulation in CD163 expression 4.94% compared 
to infected un-polarized M0 (7.31%). Infected M2, cells polarized by IL-4 (7.74%) and 
IL-13 (6.69%), showed no change in CD163 expression when compared to control. 
However, the expression of CD163 was increased in IL-10 activated M2c ells (9.29%) 
after viral infection compared to infected M0. Down-regulation was observed in CD163 
expression on M1 macrophages (4.94%) and IL-4 activated M2 cells (7.74%) upon 
infection when compared them with uninfected M1 (12.96%) and M2 macrophages 
activated by IL-4 (10.45%) whereas an increase was noticed in M2 macrophages 
activated by IL-10 (9.29%) after HSV-1 infection compared to uninfected M2 cells 
activated by IL-10 (7.40%). The experiments were done in triplicate. 
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Figure 16 A. Expression of CD200R levels in untreated and stimulated macrophages 
phenotypes before HSV-1 infection. Flow cytometry analysis was conducted at 24 
hours using negative isotype antibodies to set quadrants. M2 macrophages polarized by 
IL-14 displayed an increase in CD200R expression to (11.81%) when compared to 
untreated control (8.98%) whereas M1 and M2 macrophages activated by IL-10 and IL-
13 showed a slight decrease in CD200R expression (7.30%, 6.7%, and 7.23%, 
respectively) compared to untreated M0.   
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 Figure 16 B. Expression of CD200R in uninfected macrophages at 24 hours of 
stimulation. Higher, but not significant, differences in CD200R expression were shown 
among un-infected macrophages subpopulations. The experiments were done three times. 
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Figure 17 A. CD200R expressions in macrophages subpopulations 24 hours after 
virus challenge shown by flow cytometry analysis. CD200R expression was the same 
in M2 polarized by IL-4 after infection compared to infected controls (10.34% and 
11.33%, respectively). The expression was down regulated significantly in infected M1 
cells (5.48%) (P-value <0.001, <0.005) compared to infected M2 macrophages activated 
by IL-4 and IL-10, respectively, likely due to M1 macrophage production of pro-
inflammatory cytokines. Infected M1 (5.48%) expressed low number of CD200R+ cells 
after viral infection compared to infected controls. CD200R expression was down 
regulated insignificantly in M2 macrophages activated by IL-10 (9.84%), and IL-13 
(9.98%) after HSV-1 infection compared to infected M0 macrophages.  
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Figure 17 B. CD200R expression levels in viral infected cells after 24 hours. CD200R 
expression was the same in M2 polarized by IL-4 after infection compared to infected 
controls (10.34% and 11.33%, respectively). The expression was down regulated 
significantly in infected M1 cells (5.48%) (P-value <0.001, <0.005) compared to infected 
M2 macrophages activated by IL-4 and IL-10, respectively, likely due to M1 macrophage 
production of pro-inflammatory cytokines. Infected M1 (5.48%) expressed low number 
of CD200R+ cells after viral infection compared to infected controls. CD200R 
expression was down regulated insignificantly in M2 macrophages activated by IL-10 
(9.84%), and IL-13 (9.98%) after HSV-1 infection compared to infected M0 
macrophages. The experiments were done in triplicate. 
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Figure 17 C. CD200R expressions in uninfected and viral infected macrophages at 
24 hours. CD200R expression was the same in M2 polarized by IL-4 after infection 
compared to infected controls (10.34% and 11.33%, respectively). The expression was 
down regulated significantly in infected M1 cells (5.48%) (P-value <0.001, <0.005) 
compared to infected M2 macrophages activated by IL-4 and IL-10, respectively.  The 
infected M1 cell population that expressed CD200R after viral infection was only 
(5.48%) of the total M1 population. CD200R expression was down regulated 
insignificantly in M2 macrophages activated by IL-10 (9.84%), and IL-13 (9.98%) after 
HSV-1 infection compared to infected M0 macrophages. Comparing infected polarized 
macrophages with un-infected cells showed that infected M1 (5.48%) and M2 
macrophages polarized by IL-4 (10.34%) expressed lower number of CD200R+ 
compared to their uninfected counterparts (7.30% and 11.81%, respectively). However 
infected M2 cells activated by IL-10 (9.84%) and IL-13 (9.98%) displayed higher number 
of CD200R+ than uninfected M2 macrophages induced by IL-10 (6.70%) and IL-13 
(7.23%). The experiments were done three times. 
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LIST OF SUPPLEMENTAL FIGURES 	  
 
Figure S 1.	  Immunofluorescence of CD80 in un-infected RAW 264.7 macrophages, M0, M1 and M2s 18, 24, 48 hours after 
cytokines activation. Untreated control and polarized macrophages were stained with Pacific blue conjugated anti-mouse CD80 
antibodies at different times, 18, 24, and 48 hours after polarization. M1 and IL-4 activated M2 showed higher CD80 expression at 18 
hours. No differences found among macrophages in CD80 expression at 24 hours while M1 showed slightly up-regulation of CD80 
level at 48 hours. (Scale bar =50µm).	  
18 hours                                         24 hours                                         48 hours                                         
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Figure S 2: CD80 expression profiles of HSV-1 infected macrophages at 18, 24, and 48 
hours. Macrophage subpopulations were stained with Pacific blue conjugated anti-mouse CD80 
antibodies following stimulation and virus challenge at different times. CD80 expression was 
down regulated at 18 hours in M1 and IL-4 induced M2 after HSV-1 infection compare to 
uninfected ones. At 24 and 48 hours, there was no significant difference in CD80 expression 
among infected and uninfected macrophages (Scale bar =50µm). 
18 hours                                         24 hours                                         48 hours                                         
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Figure S 3. CD163 expression in un-infected RAW 264.7 macrophages, M0, M1 and M2s 18, 
24, 48 hours after cytokines activation. Untreated control and polarized macrophages were 
stained with FITC conjugated anti-CD163 antibodies at different times, 18, 24, and 48 hours after 
polarization. M1 and IL-4 activated M2 showed higher CD163 expression at 24 hours. No 
differences found among macrophages in CD163 expression at 18 and 48 hours. (Scale bar 
=50µm). 
18 hours                                         24 hours                                         48 hours                                         
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Figure S 4: CD163 expression in HSV-1 infected macrophages after 18,24, and 48 hours of 
infection. No observable differences were shown in virus infected M0, M1, and M2 activated 
with IL-4, IL-10, and IL-13 in CD163 when compared to non-infected cells at 18 and 48 hours. 
Whereas there was an un-significantly difference was noticed in virus- infected M2 induced by 
IL-10 after 24 hours post-infection compare to its uninfected counterpart (Scale bar =50µm). 
18 hours                                         24 hours                                         48 hours                                         
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Figure S 5. Expression of CD200R in un-infected RAW 264.7 macrophages, M0, M1 and 
M2 subtypes after 18, 24, 48 hours of cytokines activation. Untreated control and polarized 
macrophages were stained with Alexa Fluor 488 conjugated anti-CD200R	   antibodies	   at	  
different	   times,	   18,	   24,	   and	   48	   hours	   after	   polarization.	  M1 and IL-4 activated M2 showed 
higher CD200R expression at 18 hours. No differences found among macrophages in CD200R 
expression at 24. At 48 hours M2 induced by IL-10 showed higher CD200R expression. (Scale 
bar =50µm). 
18 hours                                         24 hours                                         48 hours                                         
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Figure S 6: Expression of CD200R in virus infected RAW 264.7 macrophages at different 
time frames. At 18 hours M0 and M1 macrophages showed the same expression of CD200R 
before and upon HSV-1 infection. However, infected M2 induced by IL-4 showed down 
regulation or no CD200R expression at the same time. IL-10 and IL-13 activated M2 exhibited 
very low numbers of CD200R+ cells upon 18 hours of virus infection. No differences in number 
of CD200R+ cells among infected and uninfected macrophages at 24 hours after infection and 
polarization. At 48 hours, the same level of CD200R expression was shown among infected and 
18 hours                                         24 hours                                         48 hours                                         
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uninfected M2 induced by IL-10 and IL-13 while M1 and M2 activated with IL-4 showed more 
expression after virus infection in comparison to uninfected cells (Scale bar =50µm). 
 
 
	  
	  
	  
	  
	  
